These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1835941)

  • 41. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histiocytosis-X cells express C3b, C3d, and C3bi receptor (CR1, CR2, and CR3) antigens.
    Bieber T; Hanau D; Heid E; Kazatchkine MD
    Arch Dermatol Res; 1985; 277(6):496-8. PubMed ID: 2932063
    [No Abstract]   [Full Text] [Related]  

  • 43. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
    Thornton BP; Vetvicka V; Ross GD
    Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
    Fischer E; Appay MD; Cook J; Kazatchkine MD
    J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of epithelial antigens Exo-1 and EPM-1 in human epidermal keratinocyte maturation and benign and malignant neoplasia.
    Klingel R; Boukamp P; Moll R; Tilgen W; Fusenig NE; Meyer zum Büschenfelde KH; Dippold WG
    Cancer Res; 1990 Dec; 50(23):7668-76. PubMed ID: 2253212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for three binding sites for C3 (hemolytically inactive), C3b and C3d on a CR2-positive Burkitt lymphoma-derived cell line (Raji).
    Barile G; Di Renzo L; Lipari M; Frati L; Faggioni A
    FEBS Lett; 1993 Jun; 324(3):319-24. PubMed ID: 8405374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of OKM5 antigen on keratinocytes in some dermatoses.
    He C; Zhao Y; Chen HD
    J Dermatol; 1991 Apr; 18(4):196-200. PubMed ID: 1717529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of CD36 (OKM5) antigen on epidermal cells in normal and diseased skin.
    Juhlin L
    Acta Derm Venereol; 1989; 69(5):403-6. PubMed ID: 2572105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
    Kalli KR; Ahearn JM; Fearon DT
    J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
    Fearon DT; Ahearn JM
    Curr Top Microbiol Immunol; 1990; 153():83-98. PubMed ID: 2153507
    [No Abstract]   [Full Text] [Related]  

  • 52. Structure and signalling functions of C3 receptors on human B cells.
    Frade R
    Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cellular microenvironment and neoplastic population in mycosis fungoides skin lesions: a clinicopathological correlation.
    Iliadis A; Koletsa T; Patsatsi A; Georgiou E; Sotiriadis D; Kostopoulos I
    Eur J Dermatol; 2016 Dec; 26(6):566-571. PubMed ID: 27545221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry.
    Rask R; Rasmussen JM; Hansen HV; Bysted P; Svehag SE
    J Clin Lab Immunol; 1988 Mar; 25(3):153-6. PubMed ID: 2969415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
    Arvieux J; Yssel H; Colomb MG
    Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutaneous expression of Thy-1 in mycosis fungoides.
    Fivenson DP; Douglass MC; Nickoloff BJ
    Am J Pathol; 1992 Dec; 141(6):1373-80. PubMed ID: 1281618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement receptors CR1 on human peripheral nerve fibres.
    Vedeler CA; Matre R
    J Neuroimmunol; 1988 Mar; 17(4):315-22. PubMed ID: 2963017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Webster CB; Holers VM
    J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.
    Griffiths CE; Voorhees JJ; Nickoloff BJ
    J Am Acad Dermatol; 1989 Apr; 20(4):617-29. PubMed ID: 2497153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.